BNP Paribas Financial Markets’s VanEck Pharmaceutical ETF PPH Stock Holding History

BNP Paribas Financial Markets’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.3M	Sell	350,600 -198,400	-36%	-$20.5M	0.01%	890
2026 Q1	$57M	Buy	549,000 +249,000	+83%	+$26.5M	0.03%	617
2025 Q4	$31M	Buy	300,000 +191,371	+176%	+$18.6M	0.01%	932
2025 Q3	$9.82M	Hold	108,629	–	–	0.01%	1550
2025 Q2	$9.56M	Hold	108,629	–	–	0.01%	1476
2025 Q1	$9.9M	Buy	108,629 +49,996	+85%	+$4.5M	0.01%	1413
2024 Q4	$5.06M	Buy	+58,633	New	+$5.3M	﹤0.01%	1765
2024 Q3	–	Sell	-1,800	Closed	-$165K	–	4216
2024 Q2	$165K	Sell	1,800 -6	-0.3%	-$536	﹤0.01%	3160
2024 Q1	$164K	Sell	1,806 -99,998	-98%	-$8.76M	﹤0.01%	3302
2023 Q4	$8.28M	Sell	101,804 -150,004	-60%	-$11.8M	0.01%	1116
2023 Q3	$20.1M	Sell	251,808 -148,992	-37%	-$12M	0.03%	608
2023 Q2	$31.6M	Buy	400,800 +300,300	+299%	+$23.5M	0.04%	434
2023 Q1	$7.8M	Hold	100,500	–	–	0.01%	1022
2022 Q4	$7.81M	Hold	100,500	–	–	0.01%	1087
2022 Q3	$6.76M	Buy	100,500 +50,500	+101%	+$3.72M	0.01%	1205
2022 Q2	$3.84M	Buy	+50,000	New	+$3.9M	0.01%	1364
2021 Q2	–	Sell	-200,000	Closed	-$13.8M	–	4095
2021 Q1	$13.8M	Buy	+200,000	New	+$13.8M	0.02%	678
2020 Q2	–	Sell	-100,406	Closed	-$5.46M	–	4371
2020 Q1	$5.46M	Sell	100,406 -904,000	-90%	-$55.7M	0.01%	941
2019 Q4	$64.5M	Buy	1,004,406 +604,406	+151%	+$36.4M	0.12%	176
2019 Q3	$22.8M	Buy	+400,000	New	+$22.9M	0.04%	450

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BNP Paribas Financial Markets's PPH Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its VanEck Pharmaceutical ETF (PPH) stake by 36% in Q2 2026, selling an estimated $20.5M and leaving 350,600 shares worth $38.3M. The position accounts for 0.01% of the portfolio, ranked #890.

BNP Paribas Financial Markets first reported a position in PPH in Q3 2019 and has held it in 20 quarters since. The position peaked at $64.5M in Q4 2019. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

BNP Paribas Financial Markets held 350,600 shares of VanEck Pharmaceutical ETF worth $38.3M as of Q2 2026.
BNP Paribas Financial Markets sold 198,400 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $20.5M.
VanEck Pharmaceutical ETF made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #890 holding.
BNP Paribas Financial Markets first reported a position in VanEck Pharmaceutical ETF in Q3 2019 and has held it in 20 quarters since.
BNP Paribas Financial Markets's VanEck Pharmaceutical ETF position peaked at $64.5M in Q4 2019.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.